Login / Register The Most Trusted Name in Medical Education

Primary Care

Elsevier's Office of Continuing Medical Education offers the most comprehensive list of primary care CME courses. Check out the list below to ramp up on the latest topics in primary care.

Thumbnail 116x140 LearningCenter v2

Progress in Pancreatic Cancer

Format: Resource Center

Welcome to the Progress in Pancreatic Cancer Learning Center. This Learning Center is a freely accessible, educational platform for healthcare providers who treat patients with pancreatic cancer

Our goal is to ensure that you – the practicing clinician – have access to the most accurate, up-to-date information for the treatment of patients with pancreatic cancer. Within this learning center, you will have access to complimentary continuing medical education (CME) activities highlighting up-to-the-minute emerging evidence that can be applied to everyday practice. Additional resources include open access to the full text of relevant peer-reviewed articles, clinical guidelines, interactive infographics, and other materials dedicated to helping you improve patient care.

As new data emerge, we will be updating the Progress in Pancreatic Cancer Learning Center with new CME activities and timely materials, so please check back often for the latest offerings.

We know you will find these resources helpful in your clinical practice, and hope that you will make the Progress in Pancreatic Cancer Learning Center your destination for pancreatic cancer education.

Take Course »

Credits: 0.75 AMA PRA Category 1 Credit™ per module
116x140 POC IT

Intrathecal Therapy for Severe Chronic Pain: From Evidence-Based Recommendations to Practical Demonstrations

Format: Webcast Series

Chronic pain affects 100 million Americans. Certain patients with chronic pain are candidates for intrathecal (IT) therapy, which can mitigate some of the risks associated with systemic opioids. Following appropriate patient selection based on medical and psychiatric history and a physical exam, a patient can begin a trial with morphine or ziconotide, the 2 US Food and Drug Administration (FDA)–approved IT therapies. Monitoring for adverse events should continue after IT pump implantation, as should monitoring for catheter- or pump-related complications. This CME-accredited Point of Care 201™ 2-part series discusses identification of candidates for IT therapy, available IT therapies, optimal treatment initiation and management, and both surgical implantation and pump refill techniques. 

Take Course »

Credits: 0.5 AMA PRA Category 1 Credit™ per module